Cargando…
Why dose adjust systemic exposure when looking for associations with adverse events in tacrolimus‐treated transplant recipients?
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688523/ https://www.ncbi.nlm.nih.gov/pubmed/31144343 http://dx.doi.org/10.1111/bcp.13984 |
_version_ | 1783613719988666368 |
---|---|
author | Robertsen, Ida Woillard, Jean‐Baptiste Åsberg, Anders |
author_facet | Robertsen, Ida Woillard, Jean‐Baptiste Åsberg, Anders |
author_sort | Robertsen, Ida |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7688523 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-76885232020-12-09 Why dose adjust systemic exposure when looking for associations with adverse events in tacrolimus‐treated transplant recipients? Robertsen, Ida Woillard, Jean‐Baptiste Åsberg, Anders Br J Clin Pharmacol Letters to the Editor John Wiley and Sons Inc. 2019-05-29 2020-12 /pmc/articles/PMC7688523/ /pubmed/31144343 http://dx.doi.org/10.1111/bcp.13984 Text en © 2019 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Letters to the Editor Robertsen, Ida Woillard, Jean‐Baptiste Åsberg, Anders Why dose adjust systemic exposure when looking for associations with adverse events in tacrolimus‐treated transplant recipients? |
title | Why dose adjust systemic exposure when looking for associations with adverse events in tacrolimus‐treated transplant recipients? |
title_full | Why dose adjust systemic exposure when looking for associations with adverse events in tacrolimus‐treated transplant recipients? |
title_fullStr | Why dose adjust systemic exposure when looking for associations with adverse events in tacrolimus‐treated transplant recipients? |
title_full_unstemmed | Why dose adjust systemic exposure when looking for associations with adverse events in tacrolimus‐treated transplant recipients? |
title_short | Why dose adjust systemic exposure when looking for associations with adverse events in tacrolimus‐treated transplant recipients? |
title_sort | why dose adjust systemic exposure when looking for associations with adverse events in tacrolimus‐treated transplant recipients? |
topic | Letters to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688523/ https://www.ncbi.nlm.nih.gov/pubmed/31144343 http://dx.doi.org/10.1111/bcp.13984 |
work_keys_str_mv | AT robertsenida whydoseadjustsystemicexposurewhenlookingforassociationswithadverseeventsintacrolimustreatedtransplantrecipients AT woillardjeanbaptiste whydoseadjustsystemicexposurewhenlookingforassociationswithadverseeventsintacrolimustreatedtransplantrecipients AT asberganders whydoseadjustsystemicexposurewhenlookingforassociationswithadverseeventsintacrolimustreatedtransplantrecipients |